<DOC>
	<DOCNO>NCT03027635</DOCNO>
	<brief_summary>Insertion tunnelated peritoneal catheter ( PleurX ) allow repeat intermittent small volume fluid drainage home . The treatment may improve management ascites beneficial effect quality life . This study aim evaluate beneficial harmful effect peritoneal catheter ( PleurX ) versus repeat large volume paracentesis patient cirrhosis diuretic resistant ascites . The trial investigator initiate , randomise , single blind , parallel arm , control trial . Tunnelated peritoneal ( PleurX ) catheter versus large volume paracentesis . All patient receive ciprofloxacin prevent spontaneous bacterial peritonitis . We include 32 adult patient cirrhosis Duration trial 18 month . The total duration follow six month . The primary outcome paracentesis free survival .</brief_summary>
	<brief_title>PEriToneal Catheter Versus Repeated Paracentesis Ascites Cirrhosis</brief_title>
	<detailed_description>Ten percent patient cirrhosis develop ascites . In 90 % patient , ascites treat diuretic . The management remain 10 % diuretic resistant ascites challenge . Symptoms include abdominal pain , dyspnoea , nausea , vomit , anorexia detrimental impact quality life . Repeated large volume paracentesis provide temporary improvement symptom . Insertion tunnelated peritoneal catheter ( PleurX ) allow repeat intermittent small volume fluid drainage home . The treatment may improve management ascites beneficial effect quality life . To evaluate beneficial harmful effect peritoneal catheter ( PleurX ) versus repeat large volume paracentesis patient cirrhosis diuretic resistant ascites . Investigator initiate , randomise , single blind , parallel arm , control trial . Due nature intervention primary outcome measure , Investigators unable conduct trial blinding patient , investigator use blind outcome assessment . Tunnelated peritoneal ( PleurX ) catheter versus large volume paracentesis . All patient receive ciprofloxacin prevent spontaneous bacterial peritonitis . The study investigator include 32 adult patient cirrhosis aetiology diuretic resistant ascites . Gastrounit , Hvidovre University Hospital , Department Gastroenterology Hepatology , Odense University Hospital , Department Gastroenterology Hepatology , Aarhus University Hospital , Centre Hepatology , UCL Institute Liver Digestive Health , Royal Free Campus , University College London , UK 18 month . The total duration follow six month . The primary outcome paracentesis free survival . Secondary outcome include cumulative number paracentesis , cirrhosis-related complication , safety , quality life , change metabolic nutritional parameter , circulatory dysfunction , renal function , cardiac output , neuro-humoral change .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Ascites</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<criteria>Cirrhosis aetiology Diuretic resistant ascites define ) inability mobilise ascites ( minimal weight loss ) despite administration maximum tolerable dose oral diuretic daily dose spironolactone 400 mg reaccumulation fluid therapeutic paracentesis within two week ii ) diureticrelated complication include ( limited ) azotemia , hepatic encephalopathy , progressive electrolyte imbalance Able read understand Danish Signed date informed consent form Willing comply study procedure available duration study Male female age Age least 18 year Expected survival least three month . Participants eligible list TIPS Serum creatinine level 135 umol/L Overt hepatic encephalopathy two week randomization Ascites due cause cirrhosis : malignant disease , congestive heart failure , endstage renal disease , pancreatitis , BuddChiari ( hepatic vein thrombosis ) , chylous ascites Ongoing intraabdominal infection ( peritonitis ) active systemic local infection , urinary tract infection pneumonia Participation clinical study may interfere participation study ; Evidence extensive ascites loculation Coagulopathy Variceal bleed within two week randomisation Intraabdominal surgery within four month randomisation Spontaneous bacterial peritonitis ( neutrophil count &gt; 250/Âµl within 24 hour randomization ) Patients increase risk procedure relate complication judge primary healthcare provider</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>diuretic resistant ascites</keyword>
	<keyword>Paracentesis</keyword>
	<keyword>PleurX</keyword>
	<keyword>Peritoneal tunnelated catheter</keyword>
</DOC>